Systematic review of progesterone use by midlife and menopausal women

Maturitas

Volumn 72, Issue 3, 2012, Pages 192-202

  Spark, M Joy ^a   Willis, Jon ^a,b  

^a LA TROBE UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Menopause symptoms; Midlife; Postmenopause; Progesterone; Sleep; Systematic review

Indexed keywords

LIPID; PROGESTERONE;

ARTERY COMPLIANCE; BEDTIME DOSAGE; BONE DENSITY; BONE TURNOVER; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; ELASTICITY; FEMALE; HORMONAL THERAPY; HUMAN; LIPID BLOOD LEVEL; MENOPAUSAL SYNDROME; MENOPAUSE; OSTEOLYSIS; POSTMENOPAUSE; PROGESTERONE BLOOD LEVEL; QUALITY OF LIFE; REVIEW; SKIN; SLEEP QUALITY; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VERBAL MEMORY;

BONE AND BONES; COGNITION; DYSSOMNIAS; FEMALE; HORMONE REPLACEMENT THERAPY; HOT FLASHES; HUMANS; LIPIDS; MENOPAUSE; PLAQUE, ATHEROSCLEROTIC; PROGESTERONE; PROGESTINS; SKIN; SLEEP;

ANIMALIA;

EID: 84861804687     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.03.015     Document Type: Review

References (53)

1. M. Schumacher, R. Guennoun, and A. Ghoumari Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system Endocrine Reviews 28 4 2007 387 439
2. I. Simpson Natural progesterone and antihypertensive action British Medical Journal (Clinical Research Edition) 290 6467 1985 557 558
3. J.T. Bromberger, L.L. Schott, and H.M. Kravitz Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN) Archives of General Psychiatry 67 6 2010 598 607
4. N.F. Woods, K. Smith-DiJulio, D.B. Percival, E.Y. Tao, H.J. Taylor, and E.S. Mitchell Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study Journal of Womens Health 16 5 2007 667 677
5. L. Dennerstein, P. Lehert, J.R. Guthrie, and H.G. Burger Modeling women's health during the menopausal transition: a longitudinal analysis Menopause 14 1 2007 53 62
6. J.B. Brown Types of ovarian activity in women and their significance: the continuum (a reinterpretation of early findings) Human Reproduction Update 17 2 2011 141 158
7. J.B. Brown, P. Harrisson, M.A. Smith, and H.G. Burger Correlations between the mucus symptoms and the hormonal markers of fertility throughout reproductive life J.J. Billings, The ovulation method 7th ed. 1983 Advocate Press Pty Ltd Melbourne 99 125
8. J.C. Prior Progesterone for symptomatic perimenopause treatment - progesterone politics, physiology and potential for perimenopause Facts, Views and Vision in ObGyn 3 2 2011 109 120
9. P.W. Smith HRT: the answers. A concise guide for solving the hormone replacement therapy puzzle 2003 Healthy Living Books Traverse City
10. U. Reiss Natural hormone balance for women 2001 Pocket Books New York
11. J.V. Wright, and J. Morgenthaler Natural hormone replacement for women over 45 1997 Smart Publications Petaluma
12. J.R. Lee Natural progesterone: the multiple roles of a remarkable hormone 1997 Jon Carpenter Publishing Charlbury
13. B.G. Wren Progesterone creams: do they work? Climacteric 6 3 2003 184 187
14. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial Journal of the American Medical Association 273 3 1995 199 208
15. G.A. Greendale, B.A. Reboussin, and P. Hogan Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial Obstetrics and Gynecology 92 6 1998 982 988
16. The Writing Group for the PEPI Trial Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial Journal of the American Medical Association 276 17 1996 1389 1396
17. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial Journal of the American Medical Association 288 3 2002 321 333
18. H.B. Leonetti, S. Longo, and J.N. Anasti Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss Obstetrics and Gynecology 94 2 1999 225 228
19. N. Pluchino, A. Cubeddu, and A. Giannini Progestogens and brain: an update Maturitas 62 4 2009 349 355
20. N. Burbos, and E. Morris Menopausal symptoms British Medical Journal Clinical Evidence 2 2010 804 http://clinicalevidence.bmj.com/ceweb/conditions/ woh/0804/0804.jsp
21. V. Seifert-Klauss, and J.C. Prior Progesterone and bone: actions promoting bone health in women Journal of Osteoporosis 2010 Article ID 845180, 18 p http://downloads.sage-hindawi.com/journals/josteo/2010/845180.pdf
22. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Annals of Internal Medicine 151 4 2009 264 269
23. Assessing risk of bias in included studies J.P. Higgins, D.G. Altman, J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions 2008 John Wiley & Sons Ltd Chichester, UK 187 241
24. G.H. Guyatt, A.D. Oxman, H.J. Schünemann, P. Tugwell, and A. Knottnerus GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology Journal of Clinical Epidemiology 64 4 2011 380 382
25. B.G. Wren, S.M. Champion, K. Willetts, R.Z. Manga, and J.A. Eden Transdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal women Menopause 10 1 2003 13 18
26. K. Stephenson, P.F. Neuenschwander, A.K. Kurdowska, B. Pinson, and C. Price Transdermal progesterone: effects on menopausal symptoms and on thrombotic, anticoagulant, and inflammatory factors in postmenopausal women International Journal of Pharmaceutical Compounding 12 4 2008 294 305
27. P. Schüssler, M. Kluge, and A. Yassouridis Progesterone reduces wakefulness in sleep EEG and has no effect on cognition in healthy postmenopausal women Psychoneuroendocrinology 33 8 2008 1124 1131
28. J.C. Prior, and C.L. Hitchcock Progesterone for vasomotor symptoms: a 12-week randomized, masked placebo-controlled trial in healthy, normal-weight women 1-20 years since final menstrual flow Endocrine Reviews 31 Suppl. 1 2010 S51
29. E. Lydeking-Olsen, J.-E. Beck-Jensen, K.D.R. Setchell, and T. Holm-Jensen Soymilk or progesterone for prevention of bone loss - a 2 year randomized, placebo-controlled trial European Journal of Nutrition 43 4 2004 246 257
30. J.H. Liu, and K.N. Muse The effects of progestins on bone density and bone metabolism in postmenopausal women: a randomized controlled trial American Journal of Obstetrics and Gynecology 192 4 2005 1316 1323
31. S.Y. Honisett, B. Pang, L. Stojanovska, K. Sudhir, and P.A. Komesaroff Progesterone does not influence vascular function in postmenopausal women Journal of Hypertension 21 6 2003 1145 1149
32. G. Holzer, E. Riegler, H. Hönigsmann, S. Farokhnia, and J.B. Schmidt Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomized study British Journal of Dermatology 153 3 2005 626 634
33. A. Caufriez, R. Leproult, M. L'Hermite-Baleriaux, M. Kerkhofs, and G. Copinschi Progesterone prevents sleep disturbances and modulates GH,TSH, and melatonin secretion in postmenopausal women Journal of Clinical Endocrinology and Metabolism 96 4 2011 E614 E623
34. B. Benster, A. Carey, F. Wadsworth, A. Vashisht, C. Domoney, and J. Studd A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women Menopause International 15 2 2009 63 69
35. B. Benster, A. Carey, F. Wadsworth, M. Griffin, A. Nicolaides, and J. Studd Double-blind placebo-controlled study to evaluate the effect of pro-juven progesterone cream on atherosclerosis and bone density Menopause International 15 3 2009 100 106
36. A. Ruiz, K. Daniels, J. Barner, J. Carson, and C. Frei Effectiveness of compounded bioidentical hormone replacement therapy: an observational cohort study BMC Womens Health 11 1 2011 27
37. M.J. Spark, R.A. Dunn, and K.L. Houlahan Women's perspective on progesterone: a qualitative study conducted in Australia International Journal of Pharmaceutical Compounding 13 4 2009 345 349
38. H.P.G. Schneider, A.H. MacLennan, and D. Feeny Assessment of health-related quality of life in menopause and aging Climacteric 11 2 2008 93 107
39. B.G. Wren Transdermal progesterone creams for postmenopausal women: more hype than hope? Medical Journal of Australia 182 5 2005 237 239
40. J. Dinger, T. Zimmermann, L.A. Heinemann, and D. Stoehr Quality of life and hormone use: new validation results of MRS scale Health and Quality of Life Outcomes 2006 4 www.hqlo.com/content/4/1/32
41. C. Travers, S.M. O'Neill, R. King, D. Battistutta, and S.K. Khoo Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status Climacteric 8 1 2005 56 62
42. L. Jaszmann, N. van Lith, and J. Zaat The perimenopausal symptoms: the statistical analysis of a survey Medical Gynaecology and Sociology 4 1969 268 277
43. B.L. Neugarten, and R.J. Kraines "Menopausal Symptoms" in women of various ages Psychosomatic Medicine 27 3 1965 266 273
44. M.L. Andersen, L.R. Bittencourt, I.B. Antunes, and S. Tufik Effects of progesterone on sleep: a possible pharmacological treatment for sleep-breathing disorders? Current Medicinal Chemistry 13 29 2006 3575 3582
45. J.C. Prior Progesterone as a bone-trophic hormone Endocrine Reviews 11 2 1990 386 398
46. J.C. Prior, F. Tremollieres, S. Forsmo, and V. Seifert-Klauss Unsuccessful attempt to demonstrate progesterone's bone formation actions American Journal of Obstetrics and Gynecology 194 5 2006 1502 1503
47. J.R. Guthrie, P.R. Ebeling, and J.L. Hopper A prospective study of bone loss in menopausal Australian-born women Osteoporosis International 8 3 1998 282 290
48. U. Kroon, G. Silfverstolpe, and L. Tengborn The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables Thrombosis and Haemostasis 71 4 1994 420 423
49. A. Fournier, F. Berrino, and F. Clavel-Chapelon Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study Breast Cancer Research and Treatment 107 1 2008 103 111
50. A. Vashisht, F. Wadsworth, A. Carey, B. Carey, and J. Studd A study to look at hormonal absorption of progesterone cream used in conjunction with transdermal estrogen Gynecological Endocrinology 21 2 2005 101 105
51. K.A. Burry, P.E. Patton, and K. Hermsmeyer Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen American Journal of Obstetrics and Gynecology 180 6 1999 1504 1511
52. A.C. Hermann, A.N. Nafziger, J. Victory, R. Kulawy, M.L. Rocci, and J.S. Bertino Over-the-counter progesterone cream produces significant drug exposure compared to a food and drug administration-approved oral progesterone product Journal of Clinical Pharmacology 45 6 2005 614 619
53. G. Guyatt, A.D. Oxman, and R. Kunz GRADE guidelines: 6. Rating the quality of evidence - imprecision Journal of Clinical Epidemiology 64 12 2011 1283 1293